Clinical Coagulation, Malmö
11 – 20 of 657
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Vägar till svensk legitimation för läkare utbildade i tredje land
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab : Results From the Phase IV HemiNorth 2 Study
(2025) In Haemophilia
- Contribution to journal › Article
-
Mark
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder : Back to the clinical phenotype
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Contribution to journal › Article
- 2024
-
Mark
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
(2024) In Haemophilia
- Contribution to journal › Article
-
Mark
Historical perspective on von Willebrand disease
(2024) p.1-6
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Textbook of von Willebrand Disease : Basic and Clinical Aspects
- Book/Report › Anthology (editor)
-
Mark
Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
- Contribution to journal › Scientific review
-
Mark
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
- Contribution to journal › Article
-
Mark
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
(2024) In Haemophilia
- Contribution to journal › Article